L.M. Shlapatska

618 total citations
25 papers, 498 citations indexed

About

L.M. Shlapatska is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, L.M. Shlapatska has authored 25 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in L.M. Shlapatska's work include Immune Cell Function and Interaction (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Galectins and Cancer Biology (5 papers). L.M. Shlapatska is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Galectins and Cancer Biology (5 papers). L.M. Shlapatska collaborates with scholars based in Ukraine, United States and France. L.M. Shlapatska's co-authors include Sidorenko Sp, Edward A. Clark, С. В. Михалап, Kim E. Nichols, Theodore J. Yun, Maria Yurchenko, Che‐Leung Law, Olga V. Yurchenko, Elena Kashuba and Johan Van Lint and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

L.M. Shlapatska

21 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.M. Shlapatska Ukraine 12 358 146 131 55 52 25 498
Heike Schmidlin Netherlands 8 434 1.2× 133 0.9× 98 0.7× 46 0.8× 38 0.7× 10 588
Jordi Sintes Spain 14 328 0.9× 101 0.7× 140 1.1× 56 1.0× 27 0.5× 17 491
John Higgins United States 10 253 0.7× 100 0.7× 204 1.6× 52 0.9× 28 0.5× 18 470
Santi Suryani Australia 7 415 1.2× 102 0.7× 94 0.7× 32 0.6× 49 0.9× 10 630
Jaydeep Bhat Germany 11 400 1.1× 219 1.5× 130 1.0× 25 0.5× 38 0.7× 23 556
Kai Sontheimer Germany 6 537 1.5× 184 1.3× 75 0.6× 45 0.8× 28 0.5× 7 653
Hart S. Dengler United States 7 448 1.3× 101 0.7× 249 1.9× 31 0.6× 55 1.1× 7 666
Anja Troeger Germany 12 170 0.5× 106 0.7× 183 1.4× 56 1.0× 104 2.0× 35 493
Pilar M. Domínguez United States 10 282 0.8× 89 0.6× 224 1.7× 57 1.0× 28 0.5× 11 518
Elisabeth Salzer Austria 10 347 1.0× 83 0.6× 114 0.9× 43 0.8× 61 1.2× 18 511

Countries citing papers authored by L.M. Shlapatska

Since Specialization
Citations

This map shows the geographic impact of L.M. Shlapatska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.M. Shlapatska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.M. Shlapatska more than expected).

Fields of papers citing papers by L.M. Shlapatska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.M. Shlapatska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.M. Shlapatska. The network helps show where L.M. Shlapatska may publish in the future.

Co-authorship network of co-authors of L.M. Shlapatska

This figure shows the co-authorship network connecting the top 25 collaborators of L.M. Shlapatska. A scholar is included among the top collaborators of L.M. Shlapatska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.M. Shlapatska. L.M. Shlapatska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shlapatska, L.M., et al.. (2024). SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. Experimental Oncology. 45(4). 457–462. 1 indexed citations
2.
Shlapatska, L.M.. (2024). BREAST CANCER CELL LINES AS EXPERIMENTAL TUMOR MODELS. 26(3). 208–215.
3.
Завелевич, М.П., et al.. (2023). EXPRESSION PATTERNS OF CD90, CD117, CD123, AND CD147 IN MATURE B CELL NEOPLASMS. 25(4). 282–286.
4.
Shlapatska, L.M., et al.. (2023). PROFILE OF CD150 EXPRESSION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA. Experimental Oncology. 44(3). 198–207. 1 indexed citations
5.
6.
Shlapatska, L.M., et al.. (2021). CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells. Neoplasma. 68(4). 760–769. 8 indexed citations
7.
Shlapatska, L.M., et al.. (2020). Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors. Experimental Oncology. 42(1). 16–24. 6 indexed citations
8.
Shlapatska, L.M., et al.. (2018). SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?. Clinical Immunology. 204. 14–22. 17 indexed citations
9.
Shlapatska, L.M., et al.. (2017). CD150 AND CD180 ARE INVOLVED IN REGULATION OF TRANSCRIPTION FACTORS EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS. Experimental Oncology. 39(4). 291–298. 7 indexed citations
10.
11.
Shlapatska, L.M., et al.. (2016). DIFFERENTIAL EXPRESSION OF CD150/SLAMF1 IN NORMAL AND MALIGNANT B CELLS ON THE DIFFERENT STAGES OF MATURATION. Experimental Oncology. 38(2). 101–107. 16 indexed citations
12.
Najakshin, Alexander M., Maria Yurchenko, L.M. Shlapatska, et al.. (2015). Expression of CD150 in Tumors of the Central Nervous System: Identification of a Novel Isoform. PLoS ONE. 10(2). e0118302–e0118302. 13 indexed citations
13.
Yurchenko, Maria, L.M. Shlapatska, & Sidorenko Sp. (2012). The multilevel regulation of CD95 signaling outcome.. PubMed. 34(3). 153–9. 15 indexed citations
14.
Yurchenko, Maria, L.M. Shlapatska, Elena Kashuba, et al.. (2011). CD150-mediated Akt signalling pathway in normal and malignant B cells.. PubMed. 33(1). 9–18. 11 indexed citations
15.
Yurchenko, Maria, et al.. (2011). Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system.. PubMed. 33(4). 206–11. 20 indexed citations
16.
Yurchenko, Maria, et al.. (2010). CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells. Immunology and Cell Biology. 88(5). 565–574. 19 indexed citations
17.
Yurchenko, Maria, et al.. (2005). The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.. PubMed. 27(1). 24–30. 12 indexed citations
18.
Михалап, С. В., L.M. Shlapatska, Olga V. Yurchenko, et al.. (2004). The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells. Blood. 104(13). 4063–4070. 38 indexed citations
19.
Shlapatska, L.M., С. В. Михалап, Theodore J. Yun, et al.. (2001). CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A. The Journal of Immunology. 166(9). 5480–5487. 182 indexed citations
20.
Михалап, С. В., et al.. (1999). CDw150 Associates with Src-Homology 2-Containing Inositol Phosphatase and Modulates CD95-Mediated Apoptosis. The Journal of Immunology. 162(10). 5719–5727. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heike Schmidlin Breakdown of academic impact, for papers by Jordi Sintes Breakdown of academic impact, for papers by John Higgins Breakdown of academic impact, for papers by Santi Suryani Breakdown of academic impact, for papers by Jaydeep Bhat Breakdown of academic impact, for papers by Kai Sontheimer Breakdown of academic impact, for papers by Hart S. Dengler Breakdown of academic impact, for papers by Anja Troeger Breakdown of academic impact, for papers by Pilar M. Domínguez Breakdown of academic impact, for papers by Elisabeth Salzer
Rankless by CCL
2026